Invesco Exchange-Traded Fund Trust II. Holdings as of May 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Invesco Private Prime FundCash or money market | 24.05% | $100.39M | 100,367,215 |
| Invesco Private Government FundCash or money market | 9.24% | $38.59M | 38,585,715 |
| Sandisk Corp.SNDK | 2.95% | $12.31M | 7,261 |
| Sezzle Inc.SEZL | 2.49% | $10.40M | 87,998 |
| Planet Labs PBCPL | 2.11% | $8.80M | 172,146 |
| Bel Fuse Inc.BELFB | 1.59% | $6.63M | 24,144 |
| Kodiak Sciences Inc.KOD | 1.37% | $5.72M | 155,825 |
| Ondas Inc.ONDS | 1.32% | $5.50M | 416,402 |
| Tango Therapeutics Inc.TNGX | 1.31% | $5.48M | 249,204 |
| TTM Technologies, Inc.TTMI | 1.27% | $5.28M | 30,411 |
| Celcuity Inc.CELC | 1.14% | $4.74M | 35,667 |
| Viasat, Inc.VSAT | 1.13% | $4.70M | 58,274 |
| Lumentum Holdings Inc.LITE | 1.11% | $4.62M | 5,403 |
| Graham Corp.GHM | 1.09% | $4.56M | 45,573 |
| MYR Group Inc.MYRG | 1.03% | $4.29M | 9,232 |
| Nuvalent, Inc. | 0.99% | $4.15M | 37,571 |
| Heritage Insurance Holdings, Inc.HRTG | 0.98% | $4.07M | 187,723 |
| Aehr Test SystemsAEHR | 0.96% | $4.01M | 43,457 |
| Praxis Precision Medicines, Inc.PRAX | 0.88% | $3.68M | 10,510 |
| Erasca, Inc.ERAS | 0.87% | $3.63M | 283,076 |
| nLight, Inc.LASR | 0.86% | $3.58M | 48,286 |
| American Public Education, Inc.APEI | 0.85% | $3.53M | 71,452 |
| TeraWulf Inc.WULF | 0.77% | $3.22M | 126,024 |
| Arteris, Inc.AIP | 0.75% | $3.13M | 87,058 |
| Intuitive Machines, Inc.LUNR | 0.75% | $3.12M | 71,205 |
| Enova International, Inc.ENVA | 0.73% | $3.05M | 18,899 |
| Acadian Asset Management Inc.AAMI | 0.72% | $3.02M | 41,697 |
| Amneal Pharmaceuticals, Inc.AMRX | 0.71% | $2.98M | 226,564 |
| Century Aluminum Co.CENX | 0.70% | $2.94M | 44,588 |
| Lincoln Educational Services Corp.LINC | 0.70% | $2.92M | 62,966 |
| Northeast Bank | 0.69% | $2.88M | 22,920 |
| Semtech Corp.SMTC | 0.69% | $2.87M | 18,832 |
| Alumis Inc.ALMS | 0.68% | $2.82M | 130,757 |
| Nektar TherapeuticsNKTR | 0.67% | $2.79M | 43,022 |
| EchoStar Corp.ECHO | 0.65% | $2.73M | 21,148 |
| Cogent Biosciences, Inc.COGT | 0.64% | $2.68M | 76,691 |
| Axsome Therapeutics, Inc.AXSM | 0.64% | $2.68M | 11,419 |
| Archrock, Inc.AROC | 0.63% | $2.65M | 79,080 |
| Capricor Therapeutics, Inc.CAPR | 0.63% | $2.62M | 87,370 |
| Vicor Corp.VICR | 0.63% | $2.61M | 7,793 |
| SELLAS Life Sciences Group, Inc.SLS | 0.61% | $2.56M | 274,459 |
| Garrett Motion Inc.GTX | 0.61% | $2.53M | 77,334 |
| DigitalOcean Holdings, Inc.DOCN | 0.59% | $2.48M | 15,892 |
| BrightSpring Health Services, Inc.BTSG | 0.57% | $2.40M | 38,835 |
| Flotek Industries, Inc.FTK | 0.57% | $2.38M | 119,128 |
| Oruka Therapeutics, Inc.ORKA | 0.57% | $2.37M | 40,547 |
| StoneX Group Inc.SNEX | 0.57% | $2.37M | 20,921 |
| Spyre Therapeutics, Inc.SYRE | 0.56% | $2.34M | 31,881 |
| Liquidia Corp.LQDA | 0.56% | $2.33M | 37,618 |
| DXP Enterprises, Inc.DXPE | 0.55% | $2.31M | 15,936 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.